Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deepa Bhojwani

Showing results (101-110 of 125) with videos related to

Pageof 13
Sort By:
Leukemia|June 3, 2026
Inotuzumab ozogamicin in individuals with Down syndrome and acute lymphoblastic leukemiaAmanda M Li, Catherine Aftandilian, Colleen Annesley, et al.
The Lancet. Haematology|June 25, 2021
Severe toxicity free survival: physician-derived definitions of unacceptable long-term toxicities following acute lymphocytic leukaemiaLiv Andrés-Jensen, Andishe Attarbaschi, Edit Bardi, et al.
Journal of the National Cancer Institute|January 17, 2024
Additive effects of TPMT and NUDT15 on thiopurine toxicity in children with acute lymphoblastic leukemia across multiethnic populationsMaud Maillard, Rina Nishii, Wenjian Yang, et al.
Ebiomedicine|April 29, 2021
Increased viral variants in children and young adults with impaired humoral immunity and persistent SARS-CoV-2 infection: A consecutive case seriesThao T Truong, Alex Ryutov, Utsav Pandey, et al.
American Journal of Hematology|February 18, 2022
Decitabine and vorinostat with FLAG chemotherapy in pediatric relapsed/refractory AML: Report from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortiumLauren Pommert, Eric S Schafer, Jemily Malvar, et al.
Research Square|August 16, 2024
Anti-CD7 allogeneic WU-CART-007 in patients with relapsed/refractory T-cell acute lymphoblastic leukemia/lymphoma: a phase 1/2 trialArmin Ghobadi, Ibrahim Aldoss, Shannon Maude, et al.
Medrxiv : the Preprint Server for Health Sciences|March 10, 2021
Persistent SARS-CoV-2 infection and increasing viral variants in children and young adults with impaired humoral immunityThao T Truong, Alex Ryutov, Utsav Pandey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2016
Clinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic LeukemiaChengcheng Liu, Wenjian Yang, Meenakshi Devidas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 12, 2021
Blinatumomab Nonresponse and High-Disease Burden Are Associated With Inferior Outcomes After CD19-CAR for B-ALLRegina M Myers, Agne Taraseviciute, Seth M Steinberg, et al.
Pediatric Blood & Cancer|February 12, 2025
Vincristine Sulfate Liposome Injection With Combination Chemotherapy for Children, Adolescents, and Young Adults With Relapsed Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia and Lymphoma Consortium TrialNirali N Shah, Eric S Schafer, Yueh-Yun Chi, et al.
Pageof 13

Showing results (101-110 of 125) with videos related to

Sort By:
Pageof 13
Leukemia|June 3, 2026
Inotuzumab ozogamicin in individuals with Down syndrome and acute lymphoblastic leukemiaAmanda M Li, Catherine Aftandilian, Colleen Annesley, et al.
The Lancet. Haematology|June 25, 2021
Severe toxicity free survival: physician-derived definitions of unacceptable long-term toxicities following acute lymphocytic leukaemiaLiv Andrés-Jensen, Andishe Attarbaschi, Edit Bardi, et al.
Journal of the National Cancer Institute|January 17, 2024
Additive effects of TPMT and NUDT15 on thiopurine toxicity in children with acute lymphoblastic leukemia across multiethnic populationsMaud Maillard, Rina Nishii, Wenjian Yang, et al.
Ebiomedicine|April 29, 2021
Increased viral variants in children and young adults with impaired humoral immunity and persistent SARS-CoV-2 infection: A consecutive case seriesThao T Truong, Alex Ryutov, Utsav Pandey, et al.
American Journal of Hematology|February 18, 2022
Decitabine and vorinostat with FLAG chemotherapy in pediatric relapsed/refractory AML: Report from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortiumLauren Pommert, Eric S Schafer, Jemily Malvar, et al.
Research Square|August 16, 2024
Anti-CD7 allogeneic WU-CART-007 in patients with relapsed/refractory T-cell acute lymphoblastic leukemia/lymphoma: a phase 1/2 trialArmin Ghobadi, Ibrahim Aldoss, Shannon Maude, et al.
Medrxiv : the Preprint Server for Health Sciences|March 10, 2021
Persistent SARS-CoV-2 infection and increasing viral variants in children and young adults with impaired humoral immunityThao T Truong, Alex Ryutov, Utsav Pandey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2016
Clinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic LeukemiaChengcheng Liu, Wenjian Yang, Meenakshi Devidas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 12, 2021
Blinatumomab Nonresponse and High-Disease Burden Are Associated With Inferior Outcomes After CD19-CAR for B-ALLRegina M Myers, Agne Taraseviciute, Seth M Steinberg, et al.
Pediatric Blood & Cancer|February 12, 2025
Vincristine Sulfate Liposome Injection With Combination Chemotherapy for Children, Adolescents, and Young Adults With Relapsed Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia and Lymphoma Consortium TrialNirali N Shah, Eric S Schafer, Yueh-Yun Chi, et al.
Pageof 13